192
Views
22
CrossRef citations to date
0
Altmetric
Original

Successfully Integrating an HIV Risk Reduction Intervention into a Community-Based Substance Abuse Treatment Program

, Ph.D., , Ph.D. & , Ph.D.
Pages 109-120 | Published online: 07 Jul 2009

REFERENCES

  • Centers for Disease Control and Prevention. Special data request. Available at http://www.statehealthfacts.kiff.org (Accessed August 18, 2004, from http://www.statehealthfacts.kff.org).
  • Joint United Nations Programme on HIV/AIDS. Q&A II: Basic facts about the AIDS epidemic and its impact, UNAIDS questions and answers. Available at http://www.unaids.org (Accessed August 16, 2004, from http://www.unaids.org).
  • Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges LV, Ramirez G, Flores SA, Norman L, Sweat MD, Needle R. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J AIDS 2002; 30:S73–S93.
  • Copenhaver M, Fisher JD. Experts outline ways to improve the decade-long U.S. trend of 40,000 new HIV infections per year. AIDS Beh 2006; published online 1/06.
  • Institute of Medicine. In Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press, 1998.
  • Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don't train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol 2005; 73:106–115.
  • Morgenstern J, Morgan TJ, McCrady BS, Keller DS, Carroll KM. Manual-guided cognitive behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol Addict Behav 2001; 5:83–88.
  • Knudsen HK, Roman PM. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. J Subst Abuse Treat 2004; 16:353–361.
  • Schoenwald SK, Hoagwood K. Effectiveness, transportability, and dissemination of interventions: What matters when? Psychiatric Services 2001; 52:1190–1197.
  • Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol 2003; 22:223–228.
  • Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-Related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat 2004; 26:67–78.
  • Copenhaver M, Avants SK, Margolin A, Warburton LA. Intervening effectively with drug abusers infected with HIV: Taking into account the potential for cognitive impairment. J Psychoactive Drugs 2003; 35:209–218.
  • Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for harzardous drinkers in a needle exchange program. J Subst Abuse Treat 2002; 22:23–31.
  • Sterk CE, Theall KP, Elifson KW. Effectiveness of a risk reduction intervention among African-American women who use crack cocaine. AIDS Educ Prev 2003; 15:15–32.
  • Metzger D, Woody GE, Navaline H, McLellan AT, Meyers K, Boney T, Mulvaney F, Williams J, Dyanick ST, Jonson A, Davis B, Green P, Abrams M, Oglesby P, Davis R, Zanis D, Abellanas L, Incmicoski R, O'Brien CP. The Risk Assessment Battery (RAB): Validity and reliability. Presented at The Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS; October 30–November 4, 1993; Alexandria, VA.
  • Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull 1992; 111:455–477.
  • Fisher JD, Cornman DH, Osborn CY, Amico KR, Fisher WA, Friedland GA. Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative research, acceptability, and fidelity of the OPTIONS project. J AIDS 2004; 37:S78–S87.
  • Howell DC. Statistical Methods for Psychology. 3rd ed. Belmont, CA: Duxbury Press, 1992.
  • Copenhaver M, Lee IC, Harman J, Johnson BT, Carey M. Behavioral HIV risk reduction among injection drug users: Meta-analytic evidence of efficacy. J Subst Abuse Treat 2006; 31:163–171.
  • Metzger DS, Navaline H, Woody G. Drug abuse treatment as AIDS prevention. Pub Health Rep 1998; 113:97–106.
  • Pigott TD. Missing predictors in models of effect size. Eval Health Prof 2001; 24:277–307.
  • Hoagwood K, Hibbs E, Brent D, Jensen P. Introduction to the special section: Efficacy and effectiveness in studies of child and adolescent psychotherapy. J Consult Clin Psychol 1995; 63:683–687.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.